Showing 5021-5040 of 8668 for: Cochrane Systematic Reviews Back
- Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma
Cochrane Systematic Reviews, 8-Jul-2009
Allergen exposure is one of the environmental factors seemingly associated with the development of asthma. If asthma is a multi-factorial disease, it is hypothesised that prevention might only prove effective if most or all relevant environmental factors
- Monoamine oxidase B inhibitors for early Parkinson's disease
Cochrane Systematic Reviews, 14-Nov-2011
Monoamine oxidase B (MAO-B) inhibitors slow disease progression in Parkinson's disease (PD) but clinical trials have produced conflicting results.
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Systematic Reviews, 7-Oct-2009
It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD) but trials have produced conflicting results.
- Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
Cochrane Systematic Reviews, 8-Mar-2012
Fibromyalgia (FM) syndrome is a chronic condition of unknown aetiology characterised by musculoskeletal pain that often co-exists with sleep disturbance, cognitive dysfunction and fatigue. Patients often report high disability levels and poor quality of l
- Monoaminergic agonists for acute traumatic brain injury
Cochrane Systematic Reviews, 6-Dec-2010
Although there have been considerable gains in understanding the cascade of events that lead to secondary injury after traumatic brain injury (TBI), efforts to translate this understanding into new therapeutic, so-called neuroprotective approaches, have s
- Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Cochrane Systematic Reviews, 27-Mar-2013
Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing acute respiratory infections, resulting in about 3.4 million hospitalisations annually in children under five. Palivizumab is the only product approved for prevention o
- Monosodium glutamate avoidance for chronic asthma in adults and children
Cochrane Systematic Reviews, 4-Jun-2014
Monosodium glutamate (MSG) is the sodium salt of the non-essential amino acid, glutamic acid, and is used as a flavour enhancer. It has been implicated in causing adverse reactions, which have been referred to as "Chinese restaurant syndrome". Over the la
- Monotherapy laser photocoagulation for diabetic macular oedema
Cochrane Systematic Reviews, 15-Oct-2018
Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and one of the most common causes of visual impairment in people with diabetes. Clinically significant macular oedema (CSMO) is the most severe form of DMO. Intravitreal antiangiogeni
- Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
Cochrane Systematic Reviews, 27-Apr-2017
There is evidence that certain antiepileptic drugs (AEDs) are teratogenic and are associated with an increased risk of congenital malformation. The majority of women with epilepsy continue taking AEDs throughout pregnancy; therefore it is important that c
- Montreal Cognitive Assessment for the detection of dementia
Cochrane Systematic Reviews, 13-Jul-2021
Dementia is a progressive syndrome of global cognitive impairment with significant health and social care costs. Global prevalence is projected to increase, particularly in resource-limited settings. Recent policy changes in Western countries to increase
- Morita therapy for anxiety disorders in adults
Cochrane Systematic Reviews, 19-Feb-2015
Morita therapy, first proposed in 1919, is a systematic psychological therapy for anxiety disorders that is based on eastern philosophy. It is mainly used as an alternative therapy for anxiety disorders in Asian countries such as Japan and China. Varying
- Morita therapy for schizophrenia
Cochrane Systematic Reviews, 25-Jul-2012
Morita therapy was founded in 1919 by Shoma Morita (1874-1938). The therapy involves a behavioural structured program to encourage an outward perspective on life and increased social functioning.
- Morning versus evening induction of labour for improving outcomes
Cochrane Systematic Reviews, 22-Jan-2013
Induction of labour is a common intervention in obstetric practice. Traditionally, in most hospitals induction of labour with medication starts early in the morning, with the start of the working day for the day shift. In human and animal studies spontane
- Morphine for chronic neuropathic pain in adults
Cochrane Systematic Reviews, 22-May-2017
Neuropathic pain, which is caused by a lesion or disease affecting the somatosensory system, may be central or peripheral in origin. Neuropathic pain often includes symptoms such as burning or shooting sensations, abnormal sensitivity to normally painless
- Mosquito larval source management for controlling malaria
Cochrane Systematic Reviews, 27-Jan-2016
Malaria is an important cause of illness and death in people living in many parts of the world, especially sub-Saharan Africa. Long-lasting insecticide treated bed nets (LLINs) and indoor residual spraying (IRS) reduce malaria transmission by targeting th
- Mosquito repellents for malaria prevention
Cochrane Systematic Reviews, 6-Feb-2018
Malaria is an important cause of illness and death across endemic regions. Considerable success against malaria has been achieved within the past decade mainly through long-lasting insecticide-treated nets (LLINs). However, elimination of the disease is p
- Mother and baby units for schizophrenia
Cochrane Systematic Reviews, 4-Oct-2011
Mother and baby units (MBUs) are recommended, in the UK, as an optimal site for treating post partum psychoses. Naturalistic studies suggest poor outcomes for mothers and their children if admission is needed during the first year after birth, but the evi
- Motivational interviewing for improving outcomes in youth living with HIV
Cochrane Systematic Reviews, 1-Aug-2012
Almost half of all the new HIV infections occur in youth. Motivational interviewing (MI) is a counselling technique that is effective in bringing about positive behavior changes in the general population. It is unclear whether it can be used to improve ou
- Motivational interviewing for improving recovery after stroke
Cochrane Systematic Reviews, 2-Jun-2015
Psychological problems are common complications following stroke that can cause stroke survivors to lack the motivation to take part in activities of daily living. Motivational interviewing provides a specific way for enhancing intrinsic motivation, which
- Motivational interviewing for smoking cessation
Cochrane Systematic Reviews, 31-Jul-2019
Motivational Interviewing (MI) is a directive patient-centred style of counselling, designed to help people to explore and resolve ambivalence about behaviour change. It was developed as a treatment for alcohol abuse, but may help people to a make a succe
